| Health / Medical Topics |
Yttrium Y 90-SMT 487
Pronunciation
A substance being studied in the treatment of some types of cancer. Yttrium Y 90-SMT 487 contains a molecule that binds to a protein found on certain types of neuroendocrine tumors (tumors that form from cells that release hormones). It also contains a radioactive substance called yttrium Y 90, which may help kill cancer cells. Yttrium Y 90-SMT 487 is a type of radioconjugate. Also called yttrium Y 90-DOTA-tyr3-octreotide and yttrium Y 90-edotreotide. (NCI Dictionary)
YOU MAY ALSO LIKE
A radioimmunoconjugate composed of a humanized monoclonal antibody (MoAb) OTSA101 against FZD10 and labeled with yttrium y 90, with potential antineoplastic…
A drug used with the drug rituximab to treat certain types of B-cell non-Hodgkin lymphoma. It is also being studied in the…
A substance being studied in the treatment of certain types of B-cell cancer. Epratuzumab is a monoclonal antibody that binds to a…
A radioconjugate consisting of the octreotide derivative edotreotide labeled with yttrium 90 (Y-90) with potential radiotherapeutic uses. Similar to octreotide, yttrium Y…
A substance being studied in the treatment of some types of cancer. Yttrium Y 90-DOTA-tyr3-octreotide contains a molecule that binds to a…
A radioconjugate of biotin and yttrium Y 90 (Y-90) linked through the bifunctional macrocyclic chelating agent tetra-azacyclododecanetetra-acetic acid (DOTA) with radioimmunotherapy…
